Ad is loading...
MENU
CLDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Celldex Therapeutics (CLDX) Ownership - Who owns Celldex Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
160
Web
https://www.celldex.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.56B
P/E Ratio
N/A
Total Cash
802.32M
Projected Growth
N/A
Total Debt
2.39M
Revenue
8.3M
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash/Share
12.09
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price
Fundamentals
CLDX
Capitalization
1.56B
P/E Ratio
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash
802M
Total Cash/Share
12.09
Total Debt
2.39M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
8.3M
ROE
N/A
Book Value
814M
P/B Ratio
1.99
Cash Flow
N/A
Earnings
-2.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66K
Current Ratio
29.36
Current Revenue Per Employee
15612.50
Dividends Per Share - Security
N/A
EBITDA
-160.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-26.24
Shares Held By Institutions
4.8B
Shares Outstanding - Current
66.3M
Total Liabilities
31.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-40.620
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of immunotherapy technologies for the treatment of cancer and other diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
160
Web
https://www.celldex.com